AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
- DOI
- 10.14814/phy2.15140
- Published
- 2021 Dec
- Container
- Physiological reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.14814/phy2.15140,
title = {AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.},
author = {Chen TJ and Mydel P and Benedyk-Machaczka M and Kamińska M and Kalucka U and Blø M and Furriol J and Gausdal G and Lorens J and Osman T and Marti HP},
year = {2021},
journal = {Physiological reports},
doi = {10.14814/phy2.15140},
url = {https://doi.org/10.14814/phy2.15140}
}RIS
TY - JOUR TI - AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model. AU - Chen TJ AU - Mydel P AU - Benedyk-Machaczka M AU - Kamińska M AU - Kalucka U AU - Blø M AU - Furriol J AU - Gausdal G AU - Lorens J AU - Osman T AU - Marti HP PY - 2021 JO - Physiological reports DO - 10.14814/phy2.15140 UR - https://doi.org/10.14814/phy2.15140 ER -
APA
TJ, C., P, M., M, B., M, K., U, K., M, B., J, F., G, G., J, L., T, O., & HP, M. (2021). AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.. Physiological reports. https://doi.org/10.14814/phy2.15140
Source records
- pubmed · retrieved 2026-09-25T12:19:55.039Z